Literature DB >> 166984

Thf complete amino acid sequence of C-I (apoLp-Ser), an apolipoprotein from human very low density lipoproteins.

R S Shulman, P N Herbert, K Wehrly, D S Fredrickson.   

Abstract

C-I was prepared from very low density lipoproteins of patients with familial type V hyperliporproteinemia. Peptides from tryptic digests of unmodified and succinylated C-I, chymotryptic peptides, and the products of cayanogen bromide cleavage were isolated and characterized. Sequence analysis of tryptic peptides was performed by the dansyl (5-dimethylaminonaphthalene-1-sulfonyl) technique and hydrolytic regeneration of the amino acid residues from the phenylthiocarbamyl derivatives. Alignment of the tryptic fragments within the cyanogen bromide and succinyl-tryptic peptides was confirmed by the overlap chymotryptic peptides. The complete amino acid sequence of C-I, 57 residues in length, does not reveal any obvious basis for its lipophilic properties.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166984

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Isoforms of apolipoprotein C-I associated with individuals with coronary artery disease.

Authors:  D'Vesharronne Moore; Catherine McNeal; Ronald Macfarlane
Journal:  Biochem Biophys Res Commun       Date:  2010-12-25       Impact factor: 3.575

2.  Detection of two distinct forms of apoC-I in great apes.

Authors:  Donald L Puppione; Christopher M Ryan; Sara Bassilian; Puneet Souda; Xinshu Xiao; Oliver A Ryder; Julian P Whitelegge
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2010-03       Impact factor: 2.674

3.  Apolipoprotein C-I binds more strongly to phospholipid/triolein/water than triolein/water interfaces: a possible model for inhibiting cholesterol ester transfer protein activity and triacylglycerol-rich lipoprotein uptake.

Authors:  Nathan L Meyers; Libo Wang; Donald M Small
Journal:  Biochemistry       Date:  2012-02-02       Impact factor: 3.162

4.  Proteogenomic Review of the Changes in Primate apoC-I during Evolution.

Authors:  Donald Puppione; Julian P Whitelegge
Journal:  Front Biol (Beijing)       Date:  2013-10-02

5.  The apolipoprotein CI A allele as a risk factor for Alzheimer's disease.

Authors:  S E Poduslo; M Neal; K Herring; J Shelly
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Molecular cloning and expression characterization of ApoC-I in the orange-spotted grouper.

Authors:  Y Wang; L Zhou; Z Li; J F Gui
Journal:  Fish Physiol Biochem       Date:  2008-02-10       Impact factor: 2.794

Review 7.  [Lipid-protein-interactions of human apolipoproteins-structural aspects and models of lipoproteins (author's transl)].

Authors:  G Middelhoff; J Augustin; G Klose; H Greten
Journal:  Klin Wochenschr       Date:  1977-02-15

8.  Characterisation of mRNAs encoding the precursor for human apolipoprotein CI.

Authors:  T J Knott; M E Robertson; L M Priestley; M Urdea; S Wallis; J Scott
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

9.  Primary structure of very low density apolipoprotein C-II of human plasma.

Authors:  R L Jackson; H N Baker; E B Gilliam; A M Gotto
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

10.  Cloning and sequencing of bovine apolipoprotein E complementary DNA and molecular evolution of apolipoproteins E, C-I, and C-II.

Authors:  Y W Yang; L Chan; W H Li
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.